Filing Flows › Ideaya Biosciences (IDYA) › Q3 2026 › vs Q3 2025
Ideaya Biosciences (IDYA) Q3 2026 vs Q3 2025 (year over year)
Ideaya Biosciences's revenue fell $198M (-95%) from $208M in Q3 2025 to $10.2M in Q3 2026.
Ideaya Biosciences, Q3 2026: revenue $10.2M (-95% year over year), net loss $126M, operating cash flow −$93.5M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $10.2M | $208M | −$198M | -95% |
| Other income, net | $11.9M | $10.8M | $1.1M | +10% |
| Net loss | $126M | −$119M | $245M | — |
| Costs & expenses | $148M | $219M | −$70.8M | -32% |
| Operating costs | $148M | $99.4M | $48.5M | +49% |
| Research & development | $122M | $83.0M | $38.6M | +46% |
| General & admin | $26.3M | $16.4M | $9.9M | +60% |
| Operating cash sources | $126M | −$119M | $245M | — |
| Depreciation & amortization | $614K | $661K | −$47K | -7% |
| Share-based compensation | $17.7M | $12.2M | $5.5M | +45% |
| Working capital & other | $13.9M | $10.1M | $3.8M | +38% |
| Cash used in operations | $93.5M | −$142M | $236M | — |
| Net loss absorbed | $126M | −$119M | $245M | — |
Questions
How much did Ideaya Biosciences's revenue grow year over year in Q3 2026?
Ideaya Biosciences's revenue fell $198M (-95%) from $208M in Q3 2025 to $10.2M in Q3 2026.